Liposomes in Diagnostic Imaging – Comparison of Modalities – In-vivo Visualization of Liposomes -

References

• Weinmann H. J., Brasch R. C., Press W. R., Wesby W. R., Wesby G. E. Characteristics of Gd-DTPA complex: a potential NMR contrast agent. AJR 1984; 142: 619–624
   PubMed Web of Science ®Google Scholar
• Weinmann H. J., Press W. R., Radüchel B., Platzek H, Schmitt-Willich H., Vogler H. (1990) Characteristics of Gd-DTPA and new derivatives. Proceedings of the Workshop Contrast Media in MRI, Berlin, February 1–3, 1990. Medicon, 1930
   Google Scholar
• Weinmann Laniado M., Mützel W. Pharmacokinetics of Gd-DTPA/dimeglumine after intravenous injection into healthy volunteers. Physiol. Chem. Phys. Med. NMR 1984; 16: 167–172
   PubMed Web of Science ®Google Scholar
• Bloembergen N. J. Chem. Phys. 1957; 27: 672
   Google Scholar
• Schorner W., Felix R., Laniado M., Lange L, Weinmann H. J., Claussen C., Fiegler W., Speck U., Kazner E. Testing the nuclear magnetic resonance tomography contrast medium gadolinium-DTPA in humans: Tolerance, alteration of contrast, and first clinical results. RöFo 1984; 140: 493–500
   Google Scholar
• Carr D. H., Brown J., Bydder G. M., Weinmann H. J., Speck U., Thomas D. J., Young I. R. Intravenous chelated gadolinium as a contrast agent in NMR imaging of cerebral tumours. Lancet 1984; 1: 484–486
   PubMed Web of Science ®Google Scholar
• Gore J. C., Sostman H. D., Caride V. J. Liposomes for paramagnetic contrast enhancement in n.m.r. imaging. J. Microencapsulation 1986; 3: 251–264
   PubMedGoogle Scholar
• Unger E., Winokur T., MacDougall P., Rosenblum J., Clair M., Gatenby R., Tilcock C. Hepatic metastases: liposomal Gd-DTPA enhanced MR imaging. Radiologty 1989; 171: 81–85
   Google Scholar
• Tilcock C., Ahkong Q. F., Parr M. An improved method for the preparation of liposomal gadolinium-DTPA: lonophore-mediated active entrapment of gadolinium. Invest. Radiol. 1991; 26: 242–247
   PubMed Web of Science ®Google Scholar
• Unger E. C., Shen D. K., Fritz T. A. Status of liposomes as MR contrast agents. JMRI 1993; 3: 195–198
   Google Scholar
• Unger E. C., Shen D. K., Wu G. L., Fritz T. A. Liposomes as MR contrast agents: Pros and cons. Magn. Res. Med. 1991; 22: 304–308
   PubMed Web of Science ®Google Scholar
• Unger E. C., Fritz T. A., Tilcock C. Clearance of liposomal gadolinium: in vivo decompexation. JMR1 1991; 1: 689–693
   Web of Science ®Google Scholar
• Unger E. C., Cardenas D., Zerella A., Fajardo L., Tilcock C. Biodistribution and clearance of liposomal Gadolinium-DTPA. Invest. Radiol. 1990; 25: 638–644
   PubMed Web of Science ®Google Scholar
• Tilcock C., Unger E., Cullis O., MacDougall P. Liposomal Gd-DTPA: preparation and characterization of relaxivity. Radiology 1989; 171: 77–80
   PubMed Web of Science ®Google Scholar
• Magin R. L., Wright S. M., Niesman M. R., Chan H. C., Swartz H. M. Liposome delivery of NMR contrast agents for improved tissue imaging. Magn. Res. Med. 1986; 3: 440–447
   PubMed Web of Science ®Google Scholar
• Spanjer H. H., Scherphof G. L. Targeting of lactosylceramide-containing liposomes to hepatocytes in vivo. Biochim. Biophys. Acta 1983; 734: 40–47
   PubMed Web of Science ®Google Scholar
• Devoisselle J. M., Vion-Dury J., Galons J. P., Confort-Gouny S., Coustaut D., Canioni P., Cozzone P. J. Entrapment of gadolinium-DTPA in liposomes: Characterization of vesicles by P-31 NMR spectroscopy. Invest. Radiol. 1988; 23: 719–724
   Google Scholar
• Navon G, Panigel R., Valensin G. Liposomes containing paramagnetic macromolecules as MRI contrast agents. Magn. Res. Med. 1986; 3: 876–880
   Google Scholar
• Abra R. M., Bosworth M. E., Hunt C. A. Liposomes disposition in vivo: effects of pre-dosing with liposomes. Res. Comm. Chem. Pathol. Pharmacol. 1980; 29: 349–360
   PubMedGoogle Scholar
• Bosworth M. E., Hunt C. A. Liposomes disposition in vivo II: Dose dependency. J. Pharm. Sci. 1982; 71: 100–104
   PubMed Web of Science ®Google Scholar
• Bacic G., Niesman M. R., Bennett H. F., Magin R. L., Swartz H. M. Modulation of water proton relaxation rates by liposomes containing paramagnetic materials. Magn. Res. Med. 1988; 6: 445–458
   PubMed Web of Science ®Google Scholar
• Tilcock C. Permeability of liposomal membranes to water: results from the magnetic field dependence of T1 of solvent protons in suspensions of vesicles with entrapped paramagnetic ions. Magn. Res. Med. 1992; 23: 275–286
   Google Scholar
• Tilcock C., MacDougall P., Unger E. C., Cardenas D., Fajardo L. The effect of lipid composition on the relaxivity of Gd-DTPA entrapped in lipid vesicles of defined size. Biochim. Biophys. Acta 1990; 1022: 181–186
   Google Scholar
• Barsky D., Pütz B., Schulten K., Magin R. L. Theory of paramagnetic contrast agents in liposome systems. Magn. Res. Med. 1992; 24: 1–13
   PubMed Web of Science ®Google Scholar
• Tilcock C., Ahkong Q. F., Koenig S. H., Brown R. D, III, Davis M., Kabalka G. The design of liposomal paramagnetic MR agents: effects of vesicle size upon the relaxivity of surface-incorporated lipophilic chelates. Magn. Res. Med. 1992; 27: 44–51
   PubMed Web of Science ®Google Scholar
• Grant C. W.M., Karlik S., Florio E. A liposomal MRI contrast agent: phosphatidylethanolamine-DTPA. Magn. Res. Med. 1989; 11: 236–243
   PubMed Web of Science ®Google Scholar
• Kabalka G. W., Davis M. A., Moss T. H., Buonocore E., Hubrier K., Holmberg E., Maruyama K., Huang L. Gadolinium-labeled liposomes containing various amphiphilic Gd-DTPA derivatives: targeted MRI contrast enhancement agents for the liver. Magn. Res. Med. 1991; 19: 406–415
   PubMed Web of Science ®Google Scholar
• Kunimasa J. I., Inui K. I., Hori R., Kawamura Y., Endo K. Mannancoated liposome delivery of gadolinium-diethylenetriaminepentaacetic acid, a contrast agent for use in magnetic resonance imaging. Chem. Pharm. Bull. 1992; 40: 2565–2567
   Google Scholar
• Keana J. F.W., Pou S. Nitroxide-doped liposomes containing entrapped oxidant: an approach to the “reduction problem” of nitroxides as MRI contrast agents. Physiol. Chem. Phys. Med., NMR 1985; 17: 235–240
   PubMed Web of Science ®Google Scholar
• Grant C. W.M., Barber K. R., Florio E., Karlik S. A phospolipid spin label used as a liposome-associated MRI contrast agent. Magn. Res. Med. 1987; 5: 371–376
   PubMed Web of Science ®Google Scholar
• Schwendener R. A., Wüthrich R., Duewell S., Wehrli E., Von Schulthess G. K. A pharmacokinetic and MRI study of unilamellar gadolinium-, manganese-, and iron-DTPA-stearate liposomes as organ-specific contrast agents. Invest. Radiol. 1990; 25: 922–932
   PubMed Web of Science ®Google Scholar
• Unger E. C., Fritz T. A., Shen D. K., Wu G. L. Manganese-based liposomes: comparative approaches. Invest. Radiol. 1993; 28: 933–938
   PubMed Web of Science ®Google Scholar
• Bacic G., Niesman M. R., Magin R. L., Swartz H. M. NMR and ESR study of liposome delivery of Mn2+ to murine liver. Magn. Res. Med. 1990; 13: 44–61
   PubMed Web of Science ®Google Scholar
• Unger E. C., Shen D. K., Fritz T. A., Wu G. L., Kulik New T., Matsunaga T., Ramaswami R. Liposomes bearing membrane-bound complexes of manganese as magnetic resonance contrast agents. Invest. Radiol. 1994; 29: S168–S169
   Google Scholar
• Nelson R. C., Chemzma J. L., Newberry L. B. Manganese dipyridoxyl diphosphate: effect of dose, time and pulse sequence on hepatic enhancement in rats. Invest. Radiol. 1991; 26: 569–573
   Google Scholar
• Schuhmann-Giampieri G. Liver contrast media for magnetic resonance imaging: Interrelations between pharmacokinetics and imaging. Invest. Radiol. 1993; 28: 753–761
   Google Scholar
• Weissleder R., Elizondo G., Wittenberg J., Rabito C., Bengele H., Josephson L. Ultrasmall superparamagnetic iron oxide (USPIO): characterization of a new class of contrast agents for MR imaging. Radiology 1990; 175: 489–493
   PubMed Web of Science ®Google Scholar
• Mühler A., Clement A., Vexler V., Berthezene Y., Rosenau W., Brasch R. C. Hepatobiliary enhancement with Gd-EOB-DTPA: comparison of spin-echo and STIR imaging for detection of experimental liver metastases. Radiology 1992; 184: 207–213
   Google Scholar
• Linker G., Papisov M., Schaffer B., et al. Asialofetuin-coupled monocrystalline iron oxide as an asialoglycoprotein receptor MR imaging agent. Book of Abstracts: Society of Magnetic Resonance in Medicine. Berkeley 1992; 3218
   Google Scholar
• Vogler H., Schmitt-Willich H., Bauer H., Weinmann H. J. Imaging characteristics of Gd-EOB-DTPA as a liver-specific contrast agent for MRI in the rat. Book of Abstracts: Society of Magnetic Resonance in Medicine. Berkeley 1992; 3228
   Google Scholar
• White D. L., Majumdar S., Sellham T. M. Fe-PGDF as a contrast agent for the biliary system and small intestine: MRI in dogs. Book of Abstracts: Society of Magnetic Resonance in Medicine. Berkeley 1992; 3228
   Google Scholar
• Kreft B. P., Tanimoto A., Stark D. D. The influence of tumor histology and hepatocellular injury on the enhanced detection of liver tumors by Gd-BOPTA. Book of Abstracts: Society of Magnetic Resonance in Medicine. Berkeley 1992; 3221
   Google Scholar
• Turski P., Kalinke T., Strother L., Perman W., Scott G., Kornguth S. Magnetic resonance imaging of rabbit brain after intracarotid injection of large multivesicular liposomes containing paramagnetic metals and DTPA. Magn. Res. Med. 1988; 7: 184–196
   PubMed Web of Science ®Google Scholar
• Tilcock C., Ahkong Q. F., Fisher D. Polymer-derivatized technetium 99mTc-labeled liposomal blood pool agents for nuclear medicine applications. Biochim. Biophys. Acta 1993; 1148: 77–84
   PubMed Web of Science ®Google Scholar
• Goins B., Klipper R., Rudolph A. S., Richard O. C., Blumhardt R., William T. P. Biodistribution and imaging studies of technetium-99m-labeled liposomes in rats with focal infection. J. Nucl. Med. 1993; 34: 2160–2168
   PubMed Web of Science ®Google Scholar
• Kubo A., Nakamura K., Sammiya T., Katayama M., Hashimoto T., Hashimoto S., Kobayashi H, Teramoto T. Indium-111 -labelled liposomes: dosimetry and tumour detection in patients with cancer. Eur. J. Nucl. Med. 1993; 20: 107–113
   PubMedGoogle Scholar
• Turner A. F., Presant C. A., Proffitt R. T., Williams L. E., Winsor D. W., Werner J. L. In-111-labeled liposomes: dosimetry and turnor depiction. Radiology 1988; 166: 761–765
   PubMed Web of Science ®Google Scholar
• Presant C. A., Proffitt R. T., Turner A. F., Williams L. E., Winsor D. W., Werner J. L., Kennedy P., Wiseman C., Gala K., McKenna R. J., Smith J. D., Bouzagiou S. A., Callahan R. A., Baldeschwieler J. D., Crossley R. J. Successful imaging of human cancer with indium-111-labeled phospholipid vesicles. Cancer 1988; 62: 905–911
   PubMed Web of Science ®Google Scholar
• Proffitt R. T., Williams L. E., Presant C. A., Tin G. W., Uliana J. A., Gamble A., Baldeschwieler J. D. Tumor-imaging potential of liposomes loaded with In-111-NTA: biodistribution in mice. J. Nucl. Med. 1983; 24: 45–51
   PubMed Web of Science ®Google Scholar
• Koenig S. H., Ahkong Q. F., Brown R. D., III, Lafleur M., Spiller M, Unger E., Philipps W. T., Rudolph A. S., Goins B., Timmons J. H., Klipper R., Blumhardt R. A simple method for producing a technetium-99m-labeled liposome which is stable in vivo. Nucl. Med. Biol. 1992; 19: 539–547
   Google Scholar
• Caride V., Taylor W., Cramer J., Gottschalk A. Evaluation of liposome-entrapped radioactive tracers as scanning agents. Part I: Organ distribution of liposomes [99mTc DTPA] in mice. J. Nucl. Med. 1976; 17: 1067–1072
   PubMed Web of Science ®Google Scholar
• Koenig S. H., Ahkong Q. F., Brown R. D., III, Lafleur M., Spiller M, Unger E., Philipps W. T., Rudolph A. S., Goins B., Timmons J. H., Klipper R., Blumhardt R. A simple method for producing a technetium-99m-labeled liposome which is stable in vivo. Nucl. Med. Biol. 1992; 19: 539–547
   Google Scholar
• Kremkau F. W., Gramiak R., Carstensen E. L., Shah P. M., Kramer D. H. Ultrasonic detection of cavitation at catheter tips. Am. J. Roentgenol. 1970; 110: 177–183
   Google Scholar
• Ophir J., Gobuty A., McWhirt R. E., Makad N. F. Ultrasonic backscatter from contrast producing collagen microspheres. Ultrason. Imaging 1980; 2: 67–77
   Google Scholar
• Ophir J., Parker K. J. Contrast agents in diagnostic ultrasoung. Ultrasound Med. Biol. 1989; 15: 319–333
   PubMed Web of Science ®Google Scholar
• Fritzsch T., Maaβ B., Müller B., Schöbel C., Stevens J., Siegert K. (1991) Composition and tolerance of galactose-based echo contrast media. New dimensions of contrast media. Proceedings of the Second International Symposium on Contrast Media, OsakaJapan, November 9–10, 1990, H. Kalayama, R. C. Brasch. Excerpta Medica, Amsterdam
   Google Scholar
• Fritzsch T., Schartl M., Siegert J. Preclinical and clinical results with an ultrasonic contrast agent. Invest. Radiol. 1988; 23: 302–305
   Google Scholar
• Feinstein S. B., Heidenreich P. A., Dick C. D., Schneider J. M., Pastoret A. F., Rubenstein W. A., Applebaum J., Brehm J. L., Aronson S., Ellis J., Roizen M. Albunex: a new intravascular ultrasound contrast agent: preliminary safety and efficacy results. Circulation 1988; 78: 11
   Google Scholar
• Mattrey R. F., Scheible F. W., Gosink B. B., Leopold G. R., Long D. M., Higgins C. B. Perfluorooctylbromide: a liver/spleen specific and tumor-imaging ultrasound contrast material. Radiology 1982; 145: 759–762
   PubMed Web of Science ®Google Scholar
• Berwing K., Schlepper M. Echocardiographic imaging of the left ventricle by peripheral intravenous injection of echo contrast agent. Am. Heart J. 1988; 115: 399–408
   Google Scholar
• Unger E. C., Lund P. J., Shen D. K., Fritz T. A., Yellowhair D. Nitrogen-filled liposomes as a vascular US contrast agent: preliminary evaluation. Radiology 1992; 185: 453–456
   PubMed Web of Science ®Google Scholar
• Unger E. C., Shen D. K., Fritz T. A., Lund P. J., Wu G. L., Kulik B., DeYoung D., Standen J., Ovitt T., Matsunaga T. Gas-filled liposomes as echocardiographic contrast agents in rabbits with myocardial infarcts. Invest. Radiol. 1993; 28: 1155–1159
   PubMed Web of Science ®Google Scholar
• Unger E. C., Shen D. K., Fritz T. A., Kulik B., Lund P. J., Wu G. L., Yellowhair D., Ramaswami R., Matsunaga T. Gas-filled lipid bilayers as ultrasound contrast agents. Invest. Radiol. 1994; 29: S134–S136
   Google Scholar
• Langer M., Behrends B., Langer R., Eichstädt H., Jäcke U. A. Tolerance of iopromide in angiography: a multicenter study. Recent developments in nonionic contrast media, V Taenzer, S Wende. Georg Thieme Verlag, Stuttgart 1989; 61
   Google Scholar
• Bischoff W. Clinical experience with iohexol versus iopromide in excretory urography. Recent developments in nonionic contrast media, V Taenzer, S Wende. Georg Thieme Verlag, Stuttgart 1989; 108
   Google Scholar
• Hartwig P., Mätzel W., Taenzer V. Pharmacokinetics of iohexol, iopamidol, iopromide, and iosimide compared with meglumine diatrizoate. Recent developments in nonionic contrast media, V Taenzer, S Wende. Georg Thieme Verlag, Stuttgart 1989; 220
   Google Scholar
• Mützel W., Speck U. Tolerance and biochemical pharmacology of iopromide. Contrast media, V Taenzer, E Zeitler. Georg Thieme Verlag, Stuttgart 1983; 2
   Google Scholar
• Mützel W., Speck U., Weinmann H. J. Pharmacokinetics of iopromide. Contrast media, V Taenzer, E Zeitler. Georg Thieme Verlag, Stuttgart 1983; 85
   Google Scholar
• Fritzsch T., Krause W., Weinmann H. J. Status of contrast media research in MRI, ultrasound and X-ray. Eur. Radiol. 1992; 2: 2–13
   Google Scholar
• Seltzer S. E., Shulkin P. M., Adams D. F. Usefulness of liposomes carrying iosefamate for CT opacification of liver and spleen. Am. J. Radiol. 1984; 143: 575–579
   Google Scholar
• Seltzer S. E., Gregoriadis G., Dick R. Evaluation of the dehydration-rehydration method for production of contrast-carrying liposomes. Invest. Radiol. 1988; 23: 131–138
   PubMed Web of Science ®Google Scholar
• Seltzer S. E., Janoff A. S., Blau M., Adams D. F., Boni L. T. Biodistribution and imaging characteristics of iotrolan-carrying interdigitation-fusion vesicles. Invest. Radiol. 1991; 26: S169
   PubMed Web of Science ®Google Scholar
• Seltzer S. E. Contrast-carrying liposomes: current status. Invest. Radiol. 1988; 23: S122–S125
   Google Scholar
• Seltzer S. E. The role of liposomes in diagnostic imaging. Radiology 1989; 171: 19–21
   PubMed Web of Science ®Google Scholar
• Henze A., Freise J., Magerstedt P., Majewski A. Radio-opaque liposomes for the improved visualisation of focal liver disease by computerized tomography. Comput. Med. Imaging Graph. 1989; 13: 455
   PubMed Web of Science ®Google Scholar
• Adzamli I. K., Seltzer S. E., Slifkin M., Blau M., Adams D. F. Production and characterization of improved liposomes containing radiographic contrast media. Invest. Radiol. 1990; 25: 1217
   PubMed Web of Science ®Google Scholar
• Passariello R., Pavone P., Patrizio G., Di Renzi P., Mastantuono M., Giuliani S. Liposomes loaded with nonionic contrast media: hepatosplenic computed tomographic enhancement. Invest. Radiol. 1990; 25: S92
   PubMed Web of Science ®Google Scholar
• Revel D., Corot C., Carillon Y., Dandis G., Eloy R., Amiel M. loxaglate-carrying liposomes: computed tomographic study as hepatosplenic contrast agent in rabbits. Invest Radiol. 1990; 25: S95
   PubMed Web of Science ®Google Scholar
• White C., Slifkin M., Seltzer S., Blau M., Adzamli I. K., Adams D. F. Biodistribution and clearance of contrast-carrying MREV liposomes. Invest. Radiol. 1990; 1125–9
   PubMed Web of Science ®Google Scholar
• Jendrasiak G. L., Frey G. D., Heim R. C. Liposomes as carriers of iodolipid radiocontrast agents for CT scanning of the liver. Invest. Radiol. 1985; 20: 995–1002
   PubMed Web of Science ®Google Scholar
• Krause W., Sachse A., Wagner S., Kollenkirchen U., RöBling G. Preclinical characterization of iopromide-carrying liposomes. Invest. Radiol. 1991; 26: S172–S174
   Google Scholar
• Krause W., Leike J., Sachse A., Schuhmann-Giampieri G. Characterization of iopromide liposomes. Invest. Radiol. 1993; 28: 1028–1032
   PubMed Web of Science ®Google Scholar
• Sachse A., Leike J., RöBling G., Wagner S., Krause W. Preparation and evaluation of lyophilized iopromide-carrying liposomes for liver-tumor detection. Invest. Radiol., 28: 838–844
   Google Scholar
• Mentrup E., Wowra B., Zeller W. J., Sturm V., Stricker H. In vitro release and depot effect after intratumoral application of metrizamide-containing liposomes. Arzneim. Forsch. 1989; 39: 421–423
   Google Scholar
• Ryan P. J., Davis M. A., Melchior D. L. The preparation and characterization of liposomes containing X-ray contrast agents. Biochim. Biophys. Acta. 1983; 756: 106–110
   PubMed Web of Science ®Google Scholar
• Alijakparov M. T., Rozenberg O. A., Fomina E. V., Losakova L. V., Gubareva A. V., Hanson K. P., Davidenkova E. F., Zerbin E. A. Experimentelle Hepatosplenographie nach Einführung von Liposomen mit Verografin. Med. Radiol. 1981; 11: 45
   Google Scholar
• Zalutsky M. R., Noska M. A., Seltzer S. E. Characterization of liposomes containing iodine-125-labeled radiographic contrast agents. Invest. Radiol. 1987; 22: 141–147
   Google Scholar
• Cheng K. T., Seltzer S. E., Adams D. F., Blau M. The production and evaluation of contrast-carrying liposomes made with an automatic high-pressure system. Invest. Radiol. 1987; 22: 47–55
   PubMed Web of Science ®Google Scholar
• Rosenberg O. A., Loshakova L. V., Mikhallova N. Y., Tyutin L. A., Temovoy S. K., Balashov A. T., Hanson K. P. Triombrast in liposomes for liver and spleen imaging: The first phase of the clinical trials. Centr. Okt. 1993; N5: 35–37
   Google Scholar
• Miller D. L., Vermess M., Doppman J. L. CT of the liver and spleen with EOE-13: review of 225 examinations. Am. J. Radiol. 1984; 143: 235–243
   Google Scholar
• Mattrey R. F., Schelble F. W., Gosink B. B., Leopold G. R., Long D. M., Higgins C. B. Perfluoroctylbromide: a reticuloendothelial-specific and a tumor imaging agent for computed tomography. Radiology 1983; 145: 755–758
   Google Scholar
• Violante M. R., Mare K., Fischer H. W. Biodistribution of a particulate hepatolienographic CT contrast agent: a study of iodipamide ethyl ester in the rat. Invest. Radiol. 1981; 16: 40–45
   Google Scholar
• Payne N. I., Whitehouse G. H. Delineation of the spleen by a combination of proliposomes with water-soluble contrast media: an experimental study using computed tomography. Brit. J. Radiol. 1987; 60: 535–541
   Google Scholar
• Klopp R, Niemer W, Schippel W. Verursachen Röntgenkontrastmittel bei angiographischen Untersuchungen Vertellungsstörungen der Mikrozirkulation?. Moderne Röntgenfotografie 1989; 4: 3–6
   Google Scholar
• Klopp R, Niemer W, Schippel W, Münster W. Tierexperimentelle Untersuchungen zur Mikrozirkulation ionischer und nichtionischer Röntgenkontrastmittel. Radiol Diagn 1989; 30: 324–328
   Google Scholar
• Klopp R, Niemer W, Schippel W, Münster W. Veränderungen der Mikrozirkulation nach Applikation verschiedener Röntgenkontrastmittel (Tierexperimentelle Vitalmikroskopie). Digitale Radiographie, H E Riemann, J Kollath, O Rienhoff. Schnetztor, Konstanz 1991; 264–271
   Google Scholar
• Klopp R, Niemer W, Schippel W. Kontrastmittelwirkungen auf die Flieβbedingungen der Mikrozirkulation (Tierexperimentelle Studie). Röntgenkontrastmittel: Nebenwirkungen, Prophylaxe, Therapie, P E Peters, E Zeitler. Springer Verlag, Berlin 1991; 52–64
   Google Scholar
• Klopp R, Niemer W, Schippel W, Münster W. Veränderungen der intestinalen und myocardialen Mikrozirkulation nach Applikation verschiedener Röntgenkontrastmittel. Digitale und interventionelle Radiologie bei Herz- und Gefäβerkrankungen, K Richter. Blackwell, Berlin 1992; 192–6
   Google Scholar